For PV leaders accountable for inspection outcomes: this is not about frameworks, it is about avoiding surprises under regulatory scrutiny. And it starts with the system and the teams.
Most organisations come to SMPV Limited when an inspection is announced, expected, or becoming a regular concern.
But many of the inspection issues we see originate during system setup, vendor transitions, or early scaling—not at inspection time.
Inspection pressure exposes uncertainty around governance, oversight, and evidence, not because teams lack expertise, but because systems have evolved without always being clearly defined or tested as a whole.
We do not only help teams preparing for inspections, we also provide the support to build systems that are inspection ready long term.
Inspection readiness is not achieved through repeated preparation cycles. It is achieved when the pharmacovigilance system operates in a way that can be explained, evidenced, and defended at any point in time.
When quality is properly integrated:
· Evidence is generated as part of routine work
· Documentation reflects how the system actually operates
· Governance and escalation paths are clear
· Oversight can be demonstrated without reconstruction
· Teams are confident and can explain the data and processes clearly
This is what inspectors assess in practice. And for PV Leaders, this means stronger, more efficient systems and performing teams.
SMPV Limited supports inspection readiness by strengthening how pharmacovigilance quality systems work in practice.
Inspection preparation is often the starting point.
The outcome?
We go beyond preparation, improving your systems, building efficiencies and your team's knowledge in quality along the way.

Equip your SMEs and leadership with defensible narratives inspectors respect.

Strengthen governance, oversight, and decision‑making through sustainable processes.

Understand how your PV system actually works, not just how it appears on paper.
Inspection Announced or Expected?
Begin with Stress‑Test and then stabilise control with Strengthen.
This approach serves a dual purpose: supporting the upcoming inspection whilst fixing weaknesses identified.
What you get?
Increased inspection readiness long term.
Not facing an inspection?
Start with Clarify to understand how the system operates and where targeted improvements will have the greatest impact.
This is often chosen by leaders who want confidence that their system would hold up to scrutiny, even without an inspection looming.

Understand how your pharmacovigilance system actually works and where accountability or evidence is unclear.

Stabilise governance, oversight, and evidence generation. Targeted improvements focused on ownership, decision‑making, vendor oversight, and sustainability.

Challenge the system under real inspection scenarios. The objective is not rehearsal, but confidence that the system holds up because it is understood and controlled.

If inspection readiness feels like a recurring exercise rather than a stable state, this approach is designed to address the underlying causes.



A short readiness conversation to determine whether inspection exposure is tactical or systemic.
SMPV Limited
London, United Kingdom
Copyright © 2026 SMPV Limited - All Rights Reserved.
SMPV LIMITED is a limited company registered in England and Wales.
Registered number: 11388233
Registered office: 241 Mitcham Road, Tooting, London, England, SW17 9JQ
We use strictly essential cookies. You may disable cookies, but please note that some parts of this website may become inaccessible or not function properly.
Complete the scorecard to assess your readiness and have an immediate feedback on areas to improve.
The Plug-In Strategy.
Compliance That Fits, Confidence That Lasts.